Your browser doesn't support javascript.
loading
Inhibition of the skeletal muscle Lands cycle ameliorates weakness induced by physical inactivity.
Shahtout, Justin L; Eshima, Hiroaki; Ferrara, Patrick J; Maschek, J Alan; Cox, James E; Drummond, Micah J; Funai, Katsuhiko.
Affiliation
  • Shahtout JL; Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, Utah, USA.
  • Eshima H; Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, Utah, USA.
  • Ferrara PJ; Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, Utah, USA.
  • Maschek JA; Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA.
  • Cox JE; Nagasaki International University, Sasebo, Japan.
  • Drummond MJ; Diabetes and Metabolism Research Center, University of Utah, Salt Lake City, Utah, USA.
  • Funai K; Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA.
J Cachexia Sarcopenia Muscle ; 15(1): 319-330, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38123161
ABSTRACT

BACKGROUND:

Lipid hydroperoxides (LOOH) have been implicated in skeletal muscle atrophy with age and disuse. Lysophosphatidylcholine acyltransferase 3 (LPCAT3), an enzyme of the Lands cycle, conjugates a polyunsaturated fatty acyl chain to a lysophospholipid to form a polyunsaturated fatty acid containing phospholipid (PUFA-PL) molecule, providing substrates for LOOH propagation. Previous studies suggest that inhibition of the Lands cycle is an effective strategy to suppress LOOH. Mice with skeletal muscle-specific tamoxifen-inducible knockout of LPCAT3 (LPCAT3-MKO) were utilized to determine if muscle-specific attenuation of LOOH may alleviate muscle atrophy and weakness with disuse.

METHODS:

LPCAT3-MKO and control mice underwent 7 days of sham or hindlimb unloading (HU model) to study muscle mass and force-generating capacity. LOOH was assessed by quantifying 4-hydroxynonenal (4-HNE)-conjugated peptides. Quantitative PCR and lipid mass spectrometry were used to validate LPCAT3 deletion.

RESULTS:

Seven days of HU was sufficient to induce muscle atrophy and weakness concomitant to a ~2-fold increase in 4-HNE (P = 0.0069). Deletion of LPCAT3 reversed HU-induced increase in muscle 4-HNE (P = 0.0256). No difference was found in body mass, body composition, or caloric intake between genotypes. The soleus (SOL) and plantaris (PLANT) muscles of the LPCAT3-MKO mice experienced ~15% and ~40% less atrophy than controls, respectively. (P = 0.0011 and P = 0.0265). Type I and IIa SOL myofibers experienced a ~40% decrease in cross sectional area (CSA), which was attenuated to only 15% in the LPCAT3-MKO mice (P = 0.0170 and P = 0.0411, respectively). Strikingly, SOL muscles were fully protected and extensor digitorum longus (EDL) muscles experienced a ~35% protection from HU-induced reduction in force-generating capacity in the LPCAT3-MKO mice compared with controls (P < 0.0001 for both muscles).

CONCLUSIONS:

Our findings demonstrate that attenuation of skeletal muscle lipid hydroperoxides is sufficient to restore its function, in particular a protection from reduction in muscle specific force. Our findings suggest muscle lipid peroxidation contributes to atrophy and weakness induced by disuse in mice.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Muscular Atrophy / Muscle, Skeletal Limits: Animals Language: En Journal: J Cachexia Sarcopenia Muscle Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Muscular Atrophy / Muscle, Skeletal Limits: Animals Language: En Journal: J Cachexia Sarcopenia Muscle Year: 2024 Document type: Article Affiliation country: Country of publication: